Replies to post #114452 on Biotech Values

[DewDiligence]

MNTA’s 4Q10 revenue from the Lovenox profit share was $52.4M, 31% of the $170M of 4Q10 in-market Lovenox sales booked by NVS.

For profit-share calculation, NVS’ Lovenox operating margin in 4Q10 was 68.5%.

[10nisman]

MNTA

For the fourth quarter of 2010 the Company reported a net income of $36.3 million, or $0.77 per diluted share

Gross margin's on mL appear to be approximately 68.5% up from 60% in Q3. I expected a little improvement so this was a very nice surprise. Also, other income was $956K in the quarter adding 2 cents to EPS. I assume this is investment gains on MNTA's cash balance?..

10nis